T-ZELL-REZEPTOREN

Patent europeic · EP3433270 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3433270
Numer da la dumonda
EP17715521
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-03-2017
Publitgà
30-01-2019
Concedì
20-09-2023
La protecziun finescha il pli tard
21-03-2037
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07K 14/725 (2006.01)
Prioritad
GB 201604953 23.03.2016
Dumonda PCT
PCT/GB2017/050805 22.03.2017
Publicaziun PCT
WO2017/163064 28.09.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 31-07-2024

    Midada

    Published in Swissreg on 31.07.2024

  4. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  5. 20-09-2023

    Concedì

    Published in Swissreg on 20.09.2023

Partidas

Possessur

Immunocore Limited

92 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, GB

Inventur

LI, Yi

Abingdon Oxfordshire OX14 4RY, GB

MAHON, Tara

Abingdon Oxfordshire OX14 4RY, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.